DIFFERENTIAL LOCALIZATION OF DOPAMINE D1-RECEPTORS AND D2 RECEPTORS IN RAT RETINA

被引:0
作者
TRAN, VT [1 ]
DICKMAN, M [1 ]
机构
[1] UNIV SO CALIF,SCH MED,DEPT OPHTHALMOL,LOS ANGELES,CA 90033
关键词
RAT RETINA; DOPAMINE RECEPTORS; D1-RECEPTORS; D2-RECEPTORS; AUTORADIOGRAPHY;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Dopamine interacts with distinct receptors on different target neurons in the rat retina. Dopamine receptors were labeled in the rat retina by autoradiography using H-3-SCH-23390 and H-3-spiperone binding to retinal sections. The H-3-SCH-23390 binding to D1 receptors was most concentrated in the inner plexiform, inner nuclear, and ganglion cell layers; it was absent from the outer nuclear layer and the photoreceptor inner and outer segments. Competition studies indicated that H-3-SCH-23390 binding to the inner retina was inhibited with high affinities by the D1-specific agonist and antagonist, SKF-38393 and SCH-23390. The D2-specific compounds were ineffective in competing for H-3-SCH-23390 binding. The H-3-spiperone binding to D2 receptors, however, was most concentrated in the photoreceptor inner and outer segments and in the outer nuclear layer. The D2-specific agonist and antagonists, such as quinpirole, sulpride, and eticlopride, competed for H-3-binding with high affinities; SCH-23390 and SKF-38393 were ineffective. The D2 receptors on the photoreceptors had a high affinity for clozapine but lower affinities for the modified benzamides. This is characteristic of a novel subtype of D2 receptors. Thus, D1 and D2 dopamine receptors are localized differentially in the rat retina to mediate different physiologic effects of dopamine.
引用
收藏
页码:1620 / 1626
页数:7
相关论文
共 50 条
  • [21] Immunohistochemical detection of dopamine D2 receptors in neuroendocrine tumours
    Pawlikowski, Marek
    Pisarek, Hanna
    Winczyk, Katarzyna
    ENDOKRYNOLOGIA POLSKA, 2011, 62 (05) : 388 - 391
  • [22] Olfactory receptor neurons express D2 dopamine receptors
    Koster, NL
    Norman, AB
    Richtand, NM
    Nickell, WT
    Puche, AC
    Pixley, SK
    Shipley, MT
    JOURNAL OF COMPARATIVE NEUROLOGY, 1999, 411 (04) : 666 - 673
  • [23] Differential Involvement of D1 and D2 Dopamine Receptors in L-DOPA-Induced Angiogenic Activity in a Rat Model of Parkinson's Disease
    Lindgren, Hanna S.
    Ohlin, K. Elisabet
    Cenci, M. Angela
    NEUROPSYCHOPHARMACOLOGY, 2009, 34 (12) : 2477 - 2488
  • [24] SPECT imaging of D2 dopamine receptors and endogenous dopamine release in mice
    Jongen, Cynthia
    de Bruin, Kora
    Beekman, Freek
    Booij, Jan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (09) : 1692 - 1698
  • [25] SPECT imaging of D2 dopamine receptors and endogenous dopamine release in mice
    Cynthia Jongen
    Kora de Bruin
    Freek Beekman
    Jan Booij
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35
  • [26] Localization of D-1 and D-2 dopamine receptors in the rat mesencephalic trigeminal nucleus by immunocytochemistry and in situ hybridization
    Lazarov, N
    Pilgrim, C
    NEUROSCIENCE LETTERS, 1997, 236 (02) : 83 - 86
  • [27] Differential Involvement of D1 and D2 Dopamine Receptors in L-DOPA-Induced Angiogenic Activity in a Rat Model of Parkinson's Disease
    Hanna S Lindgren
    K Elisabet Ohlin
    M Angela Cenci
    Neuropsychopharmacology, 2009, 34 : 2477 - 2488
  • [28] Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum
    Aubert, I
    Ghorayeb, I
    Normand, E
    Bloch, B
    JOURNAL OF COMPARATIVE NEUROLOGY, 2000, 418 (01) : 22 - 32
  • [29] QUANTITATIVE AUTORADIOGRAPHY OF DOPAMINE-D1 RECEPTORS, D2 RECEPTORS, AND DOPAMINE UPTAKE SITES IN POSTMORTEM STRIATAL SPECIMENS FROM SCHIZOPHRENIC-PATIENTS
    KNABLE, MB
    HYDE, TM
    HERMAN, MM
    CARTER, JM
    BIGELOW, L
    KLEINMAN, JE
    BIOLOGICAL PSYCHIATRY, 1994, 36 (12) : 827 - 835
  • [30] STIMULATION OF D1 AND D2 DOPAMINE-RECEPTORS PRODUCES ADDITIVE ANORECTIC EFFECTS
    LADURELLE, N
    DUTERTEBOUCHER, D
    COSTENTIN, J
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1991, 5 (06) : 481 - 490